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In evaluating outcomes in patients with end-stage kidney disease, the assessment of perceived health status (PHS) becomes as important as mor-
bidity and mortality.1 Among the differ-
ent types of treatment for chronic kidney 
disease—hemodialysis (HD), peritoneal 
dialysis (PD), and kidney transplantation 
(KT)—KT is the best choice in terms 
of longer survival, lower morbidity, and 
lower cost.2,3 Furthermore, patients with 
end-stage kidney disease after KT indicate 
better self-ratings of their health compared 
with HD and PD.1,4 
Health-related quality of life, perceived 
health status, and self-rated health (SRH) 
are all umbrella terms that encompass the 
correlations among an understanding of 
the physical, psychological, and also social 
domains, and that also protect these cor-
relations. These terms have been defi ned in 
different ways over the years.1 Substantial 
evidence has been presented in support of 
the hypothesis that SRH has a relation-
ship to mortality that is independent of the 
patient’s level of objective health status.5 
That is, independent of the patient’s objec-
tive health status, asking a relatively simple 
question on how someone rates his or her 
health in general helps identify persons at 
risk, irrespective of their clinical status.5
Benjamins et al.,6 in a longitudinal 
sample of 689,710 respondents, found that 
SRH has a signifi cantly predictive power 
for mortality risk. Burstrom et al.7 analyzed 
data on mortality rates and risk ratios of 
death during a 22-year follow-up study 
among 170,223 respondents, and their 
results show a strong association between 
“poor or fair” SRH and an increased risk of 
mortality. SRH is a personal understanding 
of someone’s own position in life and is 
a subjective, valid, and reliable factor asso-
ciated with mortality and morbidity1, 5-11; 
worse SRH is connected with higher mor-
bidity and mortality.
SRH has been included in many popu-
lation-level studies as a conversational way 
to open the topic of health status when 
it is to be covered in the interview in 
more detail.8 The determinants of SRH 
are sociodemographic characteristics (age, 
education, employment, and socioeconom-
ic status), social support (family and living 
status), health-promoting behavior (physi-
cal activity), and chronic health problems, 
including comorbidity. Poor SRH is more 
pronounced among people of higher age, 
women, the less educated, and the unem-
ployed with low socioeconomic status; 
furthermore, poor SRH is associated with 
a lack of social support, higher functional 
disability, lower physical activity, and the 
existence of multiple chronic conditions.11
Glomerular function is a physical fac-
tor refl ecting survival and vitality of the 
kidney, but surprisingly there is only limited 
evidence of its association with SRH.4,12-15 
Fujisawa et al.12 administered the Short 
Form Health Survey (SF-36) to 117 renal 
transplant patients who had undergone KT 
and examined which items affected their 
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OBJECTIVE: The aim of this study was to explore the relationship between self-rated health (SRH) in patients after 
kidney transplantation (KT) as well as graft function over time.
METHODS:  The sample consisted of 42 patients who were examined in the 3rd month (T1) and the 12th month 
after KT (T2). Sociodemographic data and data on glomerular function (GF) (Cockroft-Gault) were collected. Patients 
completed the SF-36 questionnaire measuring SRH. Linear regression was used to identify predictors of SRH at T2. 
Age, gender, change in GF, and SRH at T1 were set as the independent variables.
RESULTS: SRH and GF improved slightly over time. The fi rst model, consisting of age, gender, SRH at T1, and GF 
at T2, explained 49.9% of the variance in SRH at T2; GF at T2 did not signifi cantly contribute to the model. The 
second model, consisting of age (  0.26, 95% CI 1.087;0.035, p  0.05), change in GF between T2 and T1 
(  0.31, 95% CI 9.267;63.643, p  0.01), and SRH at T1 (  0.5, 95% CI 0.247;0,68, p  0.001), explained 
54.6% of the variance in SRH at T2.
CONCLUSIONS: Although SRH after transplantation is not associated with absolute levels of GF, there is a signifi -
cant association with the change in GF over time.
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perceived health status (PHS) after KT. 
They showed that the most important fac-
tor affecting health-related quality of life 
was the current serum creatinine level.12 
Also, in 2006 Rosenberger et al.4 explored 
predictors of PHS in 138 respondents after 
KT. They found that better kidney function 
is associated with better perceived health 
status, but only in the younger population.4 
In addition, in 2008 Saracino et al.16 con-
fi rmed that loss of renal function is associ-
ated with the deterioration of health-related 
quality of life in KT patients.
Therefore, the aim of this study was to 
explore the relationship between SRH in 
patients after KT and their graft function. 
We studied not only the association of the 
absolute level of glomerular function with 
SRH, but also the impact of a change in 
glomerular function over time on SRH.
Patients and Methods
Sample and Procedures
A group of 88 incident KT recipients from 
the eastern region of the Slovak Republic 
were invited to participate 3 months (T1) 
after transplant surgery. Data collection 
took place from February 2006 to January 
2009 in Kosice. All patients with a func-
tional graft who agreed to participate were 
included. The only exclusion criterion was 
the inability to answer questions during the 
interview due to severe dementia or mental 
retardation; thus, at the start (T1) three 
patients were excluded, and at follow-up 
12 months after transplantation (T2) two 
more patients were excluded because they 
had had a stroke. Patients completed a 
questionnaire measuring SRH and sociode-
mographic variables at T1 and T2. All 
participants were interviewed by trained 
personnel. Medical data were retrieved 
from medical records.
The local Ethics Committee approved 
the study. Only patients who signed 
informed consent prior to the study were 
included.
Measures
SRH was measured using the fi rst ques-
tion of the SF-36, which was originally 
designed for use in population surveys as 
a generic indicator of health status.6,17-18 
The SF-36 is considered a valid ques-
tionnaire, with eight subscales: physical 
functioning, social functioning, physical 
role limitations, emotional role limitations, 
mental health, vitality, pain, and general 
health perception.12,19-23 All of the items as 
well as all of the eight subscales are coded 
and transformed into a scale of 0 (poor 
health) to 100 (excellent health) in which 
they are presented as the standard SF-36, 
scores between 0 and 100, with higher 
scores indicating better health status.19 In 
addition, the single item question of the 
SF-36 on SRH can also be computed in 
this way. The validity and reliability of the 
SF-36 have been confi rmed in patients with 
renal disease, including those who have 
had KT.12,20-22 Skalská et al. validated the 
questionnaire in the Czech population.22 
The reason for only reporting the fi rst item 
instead of a broader description of per-
ceived health status in patients after KT is 
that SRH has been generally used in health 
studies as a reliable indicator of mortality 
and morbidity.6,17-18
Demographic data included age, gender, 
education, occupation, family status, and 
living status. Information about serum cre-
atinine, weight, comorbidity, immunosup-
pression treatment, and primary diagnosis of 
kidney failure were retrieved from medical 
records. Glomerular function was calculated 
using the Cockroft-Gault formula.
Statistics
Frequencies, means, medians, minimum, 
maximum, and standard deviations were 
calculated for the sample description. Next, 
the Wilcoxon signed-rank test and the sign 
test were used to detect changes in glo-
merular function and SRH. Finally, step-
wise linear regression was performed in 
order to identify predictors of SRH at T2; 
independent variables were age, gender, 
education, occupation, family status, living 
status, primary diagnosis of kidney fail-
ure, comorbidity, SRH at T1, glomerular 
function at T2, and change in glomerular 
function over time. Sociodemographic and 
medical factors were set as independent 
variables, including glomerular function 
at T2 in the fi rst model. The second model 
analyzed the change in glomerular func-
tion between T2 and T1 (GF) instead of 
the absolute level of glomerular function. 
SPSS 16.0 (SPSS, Chicago, Ill.) was used 
for statistical analyses. 
Results
From the initial 88 patients, 3 were exclud-
ed, 14 refused to participate, 13 provided 
incomplete questionnaires, and 6 refused to 
participate after initially consenting. Thus, 
52 patients were analyzed at T1 (a response 
rate of 61.2%). At follow-up, 2 more 
FIGURE 1. Flow chart diagram of study participants. KT, kidney transplantation.
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were excluded and 8 refused further par-
ticipation, meaning 42 patients remained (a 
response rate of 84.0%). Statistically, non-
respondents did not differ signifi cantly from 
participants by either age or gender. See 
Figure 1 for more detailed information. 
The mean age of participants at T1 
was 46.9  13.2, and age at T2 was 49.6  
12.2 years. The mean SRH at T1 (45.7  
28.8) did not differ signifi cantly from SRH 
at T2 (51.7  26.5). The mean glomerular 
function signifi cantly improved from 1.0  
0.27 mL/s at T1 to 1.11  0.29 mL/s at T2 
(p  0.001). See Table I for more detailed 
information.
The associations among family status, 
living status, education, and occupation, 
as well as the primary diagnosis of kid-
ney failure and SRH at T2 in both models 
were not signifi cant.  The fi rst regression 
model, consisting of age, gender, SRH 
at T1, and the current glomerular func-
tion at T2, explained 49.9% of the vari-
ance in SRH at T2. Age and SRH at T1 
contributed signifi cantly to this model, 
but the current glomerular function at T2 
did not. The second regression model, 
consisting of age, gender, SRH at T1, and 
GF (glomerular function at T2 minus 
glomerular function at T1), explained 
54.6% of the variance in SRH at T2. 
The GF contributed signifi cantly to this 
model (  0.308, p  0.01), while age 
contributed less but remained signifi cant, 
and SRH at T1 contributed similarly as in 
model 1. See Table II for more detailed 
information. 
Discussion
The aim of this study was to explore the 
relationship between SRH in patients after 
KT and their graft function. We studied 
not only the association of the absolute 
level of glomerular function with SRH, 
but also the impact of a change in glo-
merular function over time on SRH. We 
found that perceived health status at fol-
low-up is infl uenced not by the success of 
the transplantation shortly after transplant 
surgery, but rather by the change in glo-
merular function (GF) over time. In our 
fi rst model of SRH at 12 months after KT, 
the absolute level of glomerular function 
was set as an independent variable. In this 
model the absolute level of GF did not 
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contribute signifi cantly to the explanation 
of the variance in SRH. However, in the 
second model the change in GF over time 
contributed signifi cantly to the explana-
tion of the variance in SRH at 12 months 
after KT.  
In accordance with our fi ndings, Bohlke 
et al.24 found in their 2008 study evaluat-
ing employment status and its predictors 
among KT recipients that the absolute 
level of creatinine did not contribute sig-
nifi cantly to post-transplantation employ-
ment status. Economic productivity after a 
successful transplantation for patients after 
KT seemed to depend more on social deter-
minants and less on the specifi c clinical 
situation of the patients.24 In 2003 Karam 
et al. 25 asserted that respondents more than 
10 years after kidney transplantation had 
unpleasant mental and general health per-
ceptions, but their quality of life was quite 
similar to that of the general population in 
terms of social and role function.
In contrast, in 2005 Overbeck et al. 26 
showed that patients after KT had better 
health-rated quality of life compared with 
other patients with end-stage renal dis-
ease on dialysis and suggested that after 
KT, patients with higher levels of serum 
creatinine on the day of questioning had 
a signifi cantly greater impairment of their 
cognitive abilities. Rosenberger et al.,27 
however, pointed out that this fi nding 
might be caused by selection for the com-
parison and by not taking into account the 
fact that not all patients on dialysis are on 
a waiting list for transplantation, as there 
is no signifi cant difference in health-rated 
quality of life (HRQoL) between those 
patients on the waiting list and those after 
KT.27 In 2008, Saracino et al.16 explained 
renal function by using creatinine clear-
ance, which was estimated using the modi-
fi cation of diet in renal disease (MDRD) 
formula. Their study demonstrated a direct 
correlation between better creatinine clear-
ance and better HRQoL (physical function, 
role physical, vitality, and general health) 
among patients after KT. In addition, they 
found that a loss of renal function was asso-
ciated with a deterioration of HRQoL in 
patients after KT.16 Fujisawa et al.12 found 
a signifi cant positive correlation between 
serum creatinine and HRQoL. However, 
their study population was younger than 
ours. Our previous research found that kid-
ney function is a predictor of self-perceived 
health status, but only in a younger sub-
population.4 In the current study, age was 
a signifi cant predictor of SRH at T2, but 
its infl uence decreased in the presence of a 
change in glomerular function over time. 
Serum creatinine was identifi ed as one 
of the other clinical measures that was a 
signifi cant predictor of SRH in a longitu-
dinal study of a community-based sample 
consisting of 4,065 respondents.28 We were 
able to identify three studies on the rela-
tionship between serum creatinine or kid-
ney function and the SRH of patients after 
successful KT, and all of these were cross-
sectional in design.12,16 We did not fi nd any 
other longitudinal studies on the relation-
ship between the change in the absolute 
level of creatinine or kidney function over 
time and SRH, PHS, or HRQoL. This study 
is thus the fi rst longitudinal study using 
the relationship between measurements of 
patients’ graft function and subjective well-
being to identify a change in graft function 
over time in order to provide a signifi cant 
predictor for SRH.
Strengths and Limitations
The strength of this study is its longitudinal 
design, which enabled us to explore the role 
of the change over time of some variables 
and to compare them with their absolute 
levels. The limitations of this study are the 
number of participants and a fair response 
rate; however, there were no differences in 
age and gender between respondents and 
non-respondents. In contrast, all patients 
originating from one major transplant cen-
ter in Slovakia over a number of years 
were asked to participate in the study to 
prevent selection bias. Our future research 
should focus on educating patients better 
in order to prevent a lower response rate 
at baseline. In addition, we need early rec-
ognition of the issues on the questionnaire 
that are problematic for patients during the 
individual investigation. We must be able to 
explain the meaning of our research better, 
in order to improve patients’ motivation to 
participate.
Recommendations
Results must be verifi ed in a larger sample 
to allow for generalization. In addition, we 
only studied patients shortly after trans-
plantation; therefore, prolonging the study 
to a period longer than 12 months is nec-
essary. We could then verify whether the 
progress of subjective SRH remains depen-
dent on the change in glomerular function, 
or whether this applies only during the 
Table II. Regression models of predictors of SRH at T2 in Model 1 
with GF and in Model 2 with GF
Model Variable B (SE)  95% CI
1 Constant 41.764 (22.32) 3.501; 87.028
Age 0.799 (0.26) .365* 1.328; 0.270
Gender 5.321 (6.62) 0.098 8.102; 18.745
SRH at T1 0.443 (0.11) 0.481*** 0.214; 0.671
GF at T2 20.051 (10.10) 0.213 2.238; 42.341
Adjusted R2 49.9%
2 Constant 47.416 (18.32)* 10.256; 84.576
Age 0.561 (0.26) 0.257* 1.087; 0.035
Gender 5.616 (6.20) 0.103 6.968; 18.199
SRH at T1 0.463 (0.11) 0.503*** 0.247; 0.680
GF 36.455 (13.41) 0.308** 9.267; 63.643
Adjusted R2 54.6%
B, non-standardized coeffi cient; , standardized  coeffi cient; CI, confi dence interval; T1, 3 months after 
kidney transplantation; T2, 12 months after kidney transplantation; SRH, self-rated health;  GF, glomerular 
function; GF  (GF at T2) (GF at T1). Signifi cant p-values: *p 	 0.05,**p 	 0.01,***p 	 0.001.
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or whether this applies only during the 
period shortly after KT. Furthermore, the 
relationships among psychological, physi-
cal, and medical determinants associated 
with SRH should be studied.
Conclusions
Although SRH 12 months after transplanta-
tion is not associated with absolute levels 
of glomerular function, there is a signifi -
cant association with change in glomeru-
lar function over time. Improvement of 
the function of the transplanted kidney is 
connected with an improvement in SRH. 
When a patient is being treated, a positive 
or negative change in glomerular function 
may have consequences for the patient’s 
SRH and well-being. 
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